Product Overview
Retatrutide 10mg capsules represent a breakthrough in metabolic research as a next-generation "triple-agonist" peptide. Specifically, this compound targets the GLP-1 receptor, GIP receptor, and Glucagon receptor simultaneously. This mechanism is significantly broader than previous dual agonists like Tirzepatide or single agonists like Semaglutide.
Notably, Phase II clinical trials demonstrated a 24.2% mean body weight reduction at 48 weeks. These 10mg capsules offer an oral research format specifically designed for advanced metabolic signaling studies. Consequently, they allow researchers to observe receptor interactions without the invasive nature of subcutaneous injections.
Triple-Agonist Mechanism of Action
Retatrutide functions through a sophisticated synergy of three distinct signaling pathways. Specifically, researchers focus on the following mechanisms:
- GLP-1R Agonism: Actively stimulates insulin secretion and suppresses glucagon. Furthermore, it slows gastric emptying and reduces appetite via hypothalamic pathways.
- GIPR Agonism: Potentiates insulin secretion in a glucose-dependent manner. Notably, it contributes to weight loss through CNS GIPR expression.
- Glucagon Receptor Agonism: Uniquely increases hepatic fat oxidation and energy expenditure. Therefore, it drives thermogenesis via brown adipose tissue activation.
- Triple-Receptor Synergy: This combination produces additive-to-synergistic effects. As a result, it often exceeds the efficacy of any single or dual-receptor approach in experimental models.
Primary Research Applications
In controlled laboratory settings, scientists utilize Retatrutide 10mg capsules to investigate complex metabolic conditions. Specifically, research focus areas include:
- Obesity and Weight Regulation: Studying the impact of triple agonism on chronic weight management.
- Type 2 Diabetes: Analyzing glucose-dependent insulinotropic effects and blood sugar regulation.
- NAFLD and NASH: Investigating hepatic fat oxidation and its role in liver health research.
- Metabolic Syndrome: Exploring the systemic impacts of energy expenditure and thermogenesis.
- Pharmacokinetic Comparison: Comparing the efficacy of oral capsule delivery against traditional injectable vial protocols.
Product Features and Specifications
We manufacture our Retatrutide capsules to pharmaceutical-grade standards to ensure maximum purity for in vitro and metabolic investigations.
- Potency: 10mg of high-purity Retatrutide per capsule.
- Quantity: 60 capsules per bottle.
- Analytical Profile: Stable oral format ideal for comparative compound evaluation.
- Storage: Store in a cool, dry place away from sunlight to maintain peptide integrity.
Reviews
There are no reviews yet.